A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP. [electronic resource]
Producer: 20150427Description: 1541-7 p. digitalISSN:- 1528-0020
- Adolescent
- Adrenal Cortex Hormones -- therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Autoantibodies -- blood
- Child
- Combined Modality Therapy
- Drug Resistance
- Female
- Humans
- Male
- Middle Aged
- Platelet Count
- Purpura, Thrombocytopenic, Idiopathic -- blood
- Recombinant Proteins -- administration & dosage
- Recurrence
- Rituximab
- Thrombopoietin -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.